Ebastine is a second-generation antihistamine primarily used to treat allergic conditions such as
hay fever,
urticaria (hives), and other types of
allergic rhinitis. Marketed under trade names such as Kestine and Aleva, among others, Ebastine is known for its long-lasting effects and minimal sedative properties compared to first-generation antihistamines. These attributes make it a popular choice for patients requiring daily management of
allergy symptoms without the
drowsiness that can interfere with daily activities.
The development and marketing of Ebastine have been undertaken by various pharmaceutical companies globally. The drug has been extensively researched, with numerous clinical studies highlighting its efficacy and safety profile. Ebastine belongs to the piperidine class of antihistamines, characterized by their selective inhibition of peripheral
H1 receptors. This selectivity is critical in minimizing central nervous system effects, such as sedation, which are often associated with older antihistamines.
Ebastine is mainly indicated for the relief of symptoms associated with allergic rhinitis, both seasonal and perennial, as well as
chronic idiopathic urticaria. These conditions often present with symptoms such as
sneezing,
runny nose,
nasal congestion, and
itchy, watery eyes. In the case of urticaria, Ebastine helps alleviate
itching and the formation of hives. Ongoing research continues to explore additional therapeutic uses of Ebastine, including its potential role in treating other inflammatory conditions.
Ebastine works by selectively binding to peripheral
histamine H1 receptors, thereby blocking the action of histamine, a chemical released during allergic reactions. Histamine is responsible for many of the symptoms associated with allergic reactions, such as itching,
swelling, and vasodilation. By preventing histamine from binding to its receptors, Ebastine effectively reduces these symptoms.
One of the distinguishing features of Ebastine is its high affinity for H1 receptors and its prolonged duration of action. After oral administration, Ebastine is rapidly absorbed and undergoes extensive first-pass metabolism in the liver to form its active metabolite,
carebastine. This metabolite is primarily responsible for the drug’s therapeutic effects. Carebastine has a long half-life, which allows for once-daily dosing, making it convenient for patients. The onset of action for Ebastine typically occurs within 1 to 3 hours after ingestion, providing relatively quick relief from allergy symptoms.
When using Ebastine, it is crucial to follow the prescribing healthcare provider's instructions regarding dosage and administration. Ebastine is usually taken once daily, with or without food. The standard adult dose ranges from 10 to 20 mg per day, depending on the severity of symptoms and the specific condition being treated. For children, the dosage is typically adjusted based on age and weight, and a healthcare provider should determine the appropriate dose.
It is essential to swallow Ebastine tablets whole with a sufficient amount of water. Crushing or chewing the tablets can alter the drug's efficacy and absorption. For liquid formulations, it is important to use a proper measuring device to ensure accurate dosing. Patients should adhere to the prescribed schedule and avoid taking more than the recommended dose to prevent adverse effects.
Ebastine is generally well-tolerated, but like all medications, it can cause side effects. Common side effects include
headache,
dry mouth, drowsiness, and gastrointestinal disturbances such as
nausea and
abdominal pain. These side effects are usually mild and often diminish as the body adjusts to the medication. However, if they persist or become bothersome, it is advisable to consult a healthcare provider.
Serious side effects are rare but can occur. These may include severe allergic reactions such as
rash, itching, swelling (especially of the face, tongue, or throat), severe
dizziness, and
difficulty breathing. If any of these symptoms occur, immediate medical attention is necessary. Ebastine is contraindicated in patients with a known hypersensitivity to the drug or any of its components.
Caution is advised when prescribing Ebastine to patients with pre-existing medical conditions, such as severe
hepatic impairment, due to its extensive first-pass metabolism in the liver. Additionally, Ebastine should be used with caution in elderly patients and those with a history of cardiovascular conditions, as it can potentially cause QT prolongation in susceptible individuals. It is also crucial to consider the potential risks and benefits of using Ebastine during pregnancy and lactation, as sufficient data on its safety in these populations are not available.
Several other drugs can interact with Ebastine, potentially affecting its efficacy or increasing the risk of side effects. For instance, concomitant use of Ebastine with
ketoconazole,
erythromycin, or other potent
CYP3A4 inhibitors can increase plasma concentrations of Ebastine and its active metabolite, carebastine, thereby raising the potential for adverse effects. Similarly, combining Ebastine with other antihistamines or medications that prolong the QT interval, such as certain antiarrhythmics, can enhance the risk of
QT prolongation and
cardiac arrhythmias.
It is also important to inform healthcare providers of all medications, including over-the-counter drugs, supplements, and herbal products being taken, to avoid potential drug interactions. Patients should avoid the consumption of grapefruit or grapefruit juice while taking Ebastine, as it can interfere with the drug's metabolism and increase the risk of side effects.
In summary, Ebastine is a second-generation antihistamine widely used for the management of allergic conditions such as allergic rhinitis and chronic idiopathic urticaria. Its mechanism of action involves selective inhibition of peripheral H1 receptors, leading to effective relief of allergy symptoms with minimal sedation. Ebastine's convenient once-daily dosing and favorable safety profile make it a valuable option for patients. However, it is essential to use the medication as prescribed and be aware of potential side effects and drug interactions to ensure safe and effective treatment. As research continues to explore new therapeutic applications for Ebastine, it remains an important tool in the arsenal against
allergic diseases.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


